Document is current
Any future updates will be listed below
-
Authors
Aakko, Sofia
Ylitalo, Arno
Kuusanmäki, Heikki
Rannikko, Jenna H.
Björkman, Mari
Mandelin, Jami
Heckman, Caroline A.
Kontro, Mika
Hollmén, Maija
-
Funding
Funding for this research was provided by:
Suomen Kulttuurirahasto
Business Finland (8040/31/2019)
Finnish Medical Foundation
Cancer Foundation Finland
Research Council of Finland
Sigrid Jusélius foundation
- License Information
-
More Information
Article History
Received: 16 November 2024
Accepted: 7 May 2025
First Online: 14 May 2025
Declarations
:
: MH holds shares of Faron Pharmaceuticals. The other authors declare no competing interests.
